Navigation Links
Rib-X Pharmaceuticals to Present at Cambridge Healthtech Institute's 2nd Annual Challenge of Antibacterial Development Conference
Date:4/22/2008

NEW HAVEN, Conn., April 22 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, today announced that Graham Johnson, Ph.D., Chief Research Officer and Vice President, Discovery, will be presenting at the Cambridge Healthtech Institute's 2nd Annual "The Challenge of Antibacterial Development" conference on April 24, 2008 in San Diego, CA.

Dr. Johnson's presentation, entitled "Using Structure-Based Discovery to Define Novel Macrolide Antibiotics Targeting the 50S Ribosomal Subunit," will focus on Rib-X's ability to develop new antibiotic compounds using a drug discovery engine that combines a sophisticated, structure-based drug design approach with computational analyses and proprietary knowledge of the high-resolution crystal structure of the bacterial ribosome. Rib-X's most advanced discovery program is focused on engineering novel macrolides that overcome multiple forms of bacterial resistance. This discovery program has produced several series of structurally-distinct compounds effective against a wide range of bacteria, including those generally associated with nosocomial Gram-positive infections, community respiratory-tract infections and uncomplicated skin and soft tissue infections (uSSTIs) seen both in the hospital and community settings. Three distinct compound families with drug-like properties are being advanced for Phase 1 studies to commence late in 2008. In his presentation, Dr. Johnson will highlight the Rib-X structure-driven drug discovery approaches yielding this richness of novel, orally bioavailable macrolides.

About Rib-X Pharmaceuticals, Inc.

Rib-X Pharmaceuticals is a product-driven small molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics. The Company's underlying drug discovery engine capital
'/>"/>

SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
2. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect
3. Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections
4. Vion Pharmaceuticals Files Plan With Nasdaq
5. Amylin Pharmaceuticals to Webcast First Quarter Results
6. Paloma Pharmaceuticals to Present at the American Association for Cancer Research
7. Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R)
8. Peregrine Pharmaceuticals Announces Four Upcoming Presentations at the American Association for Cancer Research 2008 Annual Meeting
9. Pharmaceuticals & Biotechs to Share Insights for Developing Leaders in a Fast-Paced, Competitive Industry
10. Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
11. Diffusion Pharmaceuticals Announces Issuance of U.S. Patent No. 7351844, Titled Bipolar Trans Carotenoid Salts and Their Uses, for Its Family of First-In-Class Molecules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... researchers have developed a battery that takes advantage of ... produce electricity. Anywhere freshwater enters the sea, such ... for a power plant using such a battery, said ... who led the research team. The theoretical limiting ...
... Marshall Edwards, Inc.(Nasdaq: MSHL ), an ... therapeutics targeting cancer metabolism, announced today that an abstract ... for a late-breaking poster presentation at the American Association ... 4, 2011 at 1:00 p.m. EDT at the Orange ...
... March 29, 2011 Soligenix, Inc. (OTC Bulletin Board: ... late-stage biopharmaceutical company, announced today its financial results for ... Soligenix,s revenues for the year ended December 31, 2010 ... year, representing a decrease of $868,409, or 31%.  During ...
Cached Biology Technology:Stanford researchers use river water and salty ocean water to generate electricity 2Stanford researchers use river water and salty ocean water to generate electricity 3Marshall Edwards to Report new Data on Mitochondrial Inhibitor Program at American Association for Cancer Research Annual Meeting 2Marshall Edwards to Report new Data on Mitochondrial Inhibitor Program at American Association for Cancer Research Annual Meeting 3Soligenix Reports Year-End 2010 Financial Results and Highlights Recent Accomplishments 2Soligenix Reports Year-End 2010 Financial Results and Highlights Recent Accomplishments 3Soligenix Reports Year-End 2010 Financial Results and Highlights Recent Accomplishments 4Soligenix Reports Year-End 2010 Financial Results and Highlights Recent Accomplishments 5
(Date:4/15/2014)... April 15, 2014, Irvine, Calif. UC Irvine neurobiologists ... positive results when transplanted into the brains of mice ... pre-clinical trial is published in the journal Stem ... been shown to work in two different mouse models. ... forms of dementia, is associated with accumulation of the ...
(Date:4/15/2014)... know as early as 2020 how high sea levels ... team of researchers including Florida International University scientist Rene ... Science Foundation,s (NSF) Florida Coastal Everglades Long-Term Ecological Research ... in ecosystems from coral reefs to deserts, mountains to ... sea level rise is one of the most certain ...
(Date:4/15/2014)... Biologists at UC San Diego have succeeded in ... hormone responsible for growth and resistance to drought. ... studies to determine how the hormone helps plants ... by the continuing increase in the atmosphere,s carbon ... achievement appears in the April 15 issue of ...
Breaking Biology News(10 mins):UCI study finds modified stem cells offer potential pathway to treat Alzheimer's disease 2Long-term predictions for Miami sea level rise could be available relatively soon 2Biologists develop nanosensors to visualize movements and distribution of plant hormone 2
... --- Northwestern University has received a three-year, $1.6 million ... science research focused on understanding the chemical and biological ... The egg and sperm unite at the time of ... This single cell then divides many times, ultimately forming ...
... Ikaria Holdings, Inc., a fully,integrated critical care ... Drug Administration (FDA) has granted orphan drug designation,for ... of the incidence and,severity of delayed graft function ... Rosskamp, M.D., Executive Vice President of Research and,Development ...
... eventually led Joe Williams to hang from the limbs ... northeastern Australia. The things Williams, a University of ... amazing diversity in the world,s flowering plants, a question ... Darwin to today. Williams, findings, published online this ...
Cached Biology News:W.M. Keck Foundation grant funds reproductive science research 2W.M. Keck Foundation grant funds reproductive science research 3Ikaria(R) Receives FDA Orphan Drug Designation for Inhaled Carbon Monoxide for Delayed Graft Function in Solid Organ Transplants 2UT Knoxville professor finds unexpected key to flowering plants' diversity 2